FDA
-
-
-
-
-
-
-
Agenus Inc. (AGEN) PT Lowered to $5 at B.Riley
-
-
-
-
-
-
-
Journey Medical Corp (DERM) Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
-
-
-
-
-
-
-
Fulcrum Therapeutics (FULC) Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer
-
-
-
-
-
-
-
Johnson & Johnson (JNJ): FDA Advisers Unanimously Vote that carvykti Benefits Outweighing Risks as Earlier Treatment for a Type of Blood Cancer
-
-
-
-
-
-
-
Delcath Systems (DCTH) Announces $7M Share Private Placement at $3.72/sh
-
-
-
-
-
-
-
Viking Therapeutic (VKTX) PT Raised to $100 at BTIG
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) FDA Approves Breyanzi for Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
-
248,480 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All